Åivo J[au] - Search Results

Year	Number of Results
2012	2
2015	1
2016	2
2017	2
2018	1
2019	1
2022	0

1

Epstein-barr virus and multiple sclerosis risk in the finnish maternity cohort.

Munger KL, Hongell K, Cortese M, Åivo J, Soilu-Hänninen M, Surcel HM, Ascherio A. Munger KL, et al. Among authors: aivo j. Ann Neurol. 2019 Sep;86(3):436-442. doi: 10.1002/ana.25532. Epub 2019 Jul 3. Ann Neurol. 2019. PMID: 31226219 Free PMC article.

2

Author response: 25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort.

Munger KL, Ascherio A, Soilu-Hänninen M, Surcel HM, Åivo J. Munger KL, et al. Among authors: aivo j. Neurology. 2018 Apr 3;90(14):668-669. doi: 10.1212/WNL.0000000000005245. Neurology. 2018. PMID: 29610235 No abstract available.

3

Risk of osteoporotic fractures in multiple sclerosis patients in southwest Finland.

Åivo J, Kurki S, Sumelahti ML, Hänninen K, Ruutiainen J, Soilu-Hänninen M. Åivo J, et al. Acta Neurol Scand. 2017 May;135(5):516-521. doi: 10.1111/ane.12623. Epub 2016 Jun 22. Acta Neurol Scand. 2017. PMID: 27334254

4

25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort.

Munger KL, Hongell K, Åivo J, Soilu-Hänninen M, Surcel HM, Ascherio A. Munger KL, et al. Among authors: aivo j. Neurology. 2017 Oct 10;89(15):1578-1583. doi: 10.1212/WNL.0000000000004489. Epub 2017 Sep 13. Neurology. 2017. PMID: 28904091 Free PMC article.

5

Vitamin D Status During Pregnancy and Risk of Multiple Sclerosis in Offspring of Women in the Finnish Maternity Cohort.

Munger KL, Åivo J, Hongell K, Soilu-Hänninen M, Surcel HM, Ascherio A. Munger KL, et al. Among authors: aivo j. JAMA Neurol. 2016 May 1;73(5):515-9. doi: 10.1001/jamaneurol.2015.4800. JAMA Neurol. 2016. PMID: 26953778 Free PMC article.

6

Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-beta.

Åivo J, Hänninen A, Ilonen J, Soilu-Hänninen M. Åivo J, et al. J Neuroimmunol. 2015 Mar 15;280:12-5. doi: 10.1016/j.jneuroim.2015.01.005. Epub 2015 Jan 21. J Neuroimmunol. 2015. PMID: 25773149 Clinical Trial.

7

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.

Soilu-Hänninen M, Aivo J, Lindström BM, Elovaara I, Sumelahti ML, Färkkilä M, Tienari P, Atula S, Sarasoja T, Herrala L, Keskinarkaus I, Kruger J, Kallio T, Rocca MA, Filippi M. Soilu-Hänninen M, et al. Among authors: aivo j. J Neurol Neurosurg Psychiatry. 2012 May;83(5):565-71. doi: 10.1136/jnnp-2011-301876. Epub 2012 Feb 22. J Neurol Neurosurg Psychiatry. 2012. PMID: 22362918 Clinical Trial.

8

A Randomised, Double-Blind, Placebo-Controlled Trial with Vitamin D3 in MS: Subgroup Analysis of Patients with Baseline Disease Activity Despite Interferon Treatment.

Aivo J, Lindsröm BM, Soilu-Hänninen M. Aivo J, et al. Mult Scler Int. 2012;2012:802796. doi: 10.1155/2012/802796. Epub 2012 Aug 5. Mult Scler Int. 2012. PMID: 22919492 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results